Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Blocking Cell Movement Explored to Stop the Spread of Cancer

By BiotechDaily International staff writers
Posted on 14 Jul 2014
Print article
Image: Migrating embryonic neural crest cells (Photo courtesy of UCL - University College London).
Image: Migrating embryonic neural crest cells (Photo courtesy of UCL - University College London).
Learning more about how cells travel through the body could lead to innovative new treatments to block cancer cells from metastasizing and causing secondary tumors, according to new research.

Scientists discovered that cells can change into an invasive, liquid-like state to readily move through the thin channels in the human body. This transformation is activated by chemical signals, which could be blocked to stop cancer cells from spreading. Most cancer deaths are not caused by to primary tumors, but to secondary tumors in major organs, such as the lungs or brain, caused by cells moving from the original tumor to other places in the body.

The study led by the University College London (UCL; UK) researchers and published July 8, 2014, in the Journal of Cell Biology, used embryonic cells to better determine how groups of cells move in a developmental process similar to that exploited by cancer to spread around the body. The scientists reported that a molecule called lysophosphatidic acid (LPA) transforms cells from a solid-like to a liquid-like state, allowing cells to flow between normal tissues in the body. They were able to turn off the signals from LPA, stopping the cells from moving down the narrow, blood vessel-like channels.

Lead scientist Prof. Roberto Mayor, from the UCL department of cell and developmental biology, said, “We have found a way to stop the movement of embryonic cells by blocking LPA signals. It is likely that a similar mechanism operates during cancer invasion, which suggests a possible alternative which cancer treatments might work in the future, if therapies can be targeted to limit the tissue fluidity of tumors. Our findings are important for the fields of cell, developmental and cancer biology. Previously, we thought cells only moved around the body either individually or as groups of well-connected cells. What we have discovered is a hybrid state where cells loosen their links to neighboring cells but still move en masse together, like a liquid. Moreover, we can stop this movement.”

Related Links:

University College London



Print article

Channels

Genomics/Proteomics

view channel
Image: Molecular model of E3 ubiquitin ligase (green), E2 ubiquitin enzyme (orange), \"activated ubiquitin\" (cyan), and \"allosteric ubiquitin\" (blue) (Photo courtesy of Dr. Bernhard Lechtenberg, Sanford Burnham Prebys Medical Discovery Institute).

Researchers Resolve Molecular Structure of Critical Ubiquitin-Binding Enzyme

The molecular structure of a protein complex critically involved in diverse cellular functions such as cell signaling, DNA repair, and mounting anti-inflammatory and immune responses has been elucidated... Read more

Drug Discovery

view channel
Image: The “cellXpress” automated imaging analysis software enables to efficiently and accurately detect cellular responses (reflected in green) to nephrotoxic compounds (Photo courtesy of Agency for Science, Technology and Research (Singapore)).

First High-Throughput Imaging Platform for Predicting Kidney Toxicity of Chemicals

Researchers have developed a high-throughput platform of automated cellular imaging that efficiently and accurately predicts renal toxicity of chemical compounds without animal testing, providing an improved... Read more

Business

view channel

Purchase Agreement to Boost Ebola Vaccine Development

A deal to help boost development of a vaccine to protect against Ebolavirus infection was finalized at the recent Davos Conference in Switzerland. Gavi (Geneva, Switzerland), the global alliance for vaccines and immunizations, announced that it would spend five million USD to purchase the Ebola vaccine under development... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.